Skip to main content
. 2018 Dec 6;21(4):791–800. doi: 10.1111/dom.13575

Table 1.

Baseline demographic characteristics (potential prognostic factors): for patients achieving LDL cholesterol target in mean value

Intensive group Standard group
(n = 703) (n = 1206) P
Male 365 (51.9) 525 (43.5) <0.001*
Age, yearsa 62.7 (10.8) 63.6 (10.1) 0.23
Body mass index, kg/m2 26.2 (4.2) 25.5 (4.2) <0.001
Lipid‐lowering agentsb
None 386 (54.9) 472 (39.1) <0.001*
1 drug 316 (45.0) 733 (60.8)
≥2 drugs 1 (0.1) 1 (0.1)
Statinsb <0.001*
No 428 (60.9) 511 (42.4)
Yes 275 (39.1) 695 (57.6)
Smokingc 136 (19.3) 204 (16.9) 0.01*
Family history
Coronary artery disease 86 (12.2) 165 (13.7) 0.37*
Cerebrovascular disease 146 (20.8) 261 (21.6) 0.65*
Duration of diabetes, years 12.3 (8.3) 13.4 (9.1) 0.02
Diabetic complications
Neuropathy 217 (30.9) 382 (31.7) 0.71*
Nephropathy 385 (54.8) 614 (50.9) 0.10*
Hypertension 532 (75.7) 852 (70.6) 0.02*
Funduscopyd
Simple retinopathy 454 (64.6) 785 (65.1) 0.99*
Preproliferative retinopathy 141 (20.1) 243 (20.1)
Proliferative retinopathy 103 (14.7) 170 (14.1)
Othere 3 (0.4) 5 (0.4)
HbA1c, %a 7.71 (1.20) 7.71 (1.19) 0.91
LDL cholesterol, mmol/Lf 2.42 (0.62) 2.79 (0.61) <0.001
eGFR, mL/min/1.73 m2 75.1 (21.7) 74.6 (19.6) 0.81

Abbreviations: HbA1c, glycated haemoglobin; eGFR, estimated glomerular filtration rate.

Data are mean (SD) or n (%).

*The χ2 test without Yates' correction.

Wilcoxon rank sum test.

a

Values obtained at the time of consent.

b

Values obtained at provisional enrolment.

c

Not including past smokers.

d

Diagnosed by ophthalmologists based on the modified Davis classification.

e

Includes five patients who had a history of laser therapy but no funduscopic findings at enrolment. The remaining three patients were found to be retinopathy‐negative after enrolment.

f

Values were calculated using the Friedewald equation; LDL cholesterol = total cholesterol − [HDL cholesterol + triglycerides/5].